Quick Answer
Camp4 Therapeutics Corp reported Stockholders Equity of $47.70 million for fiscal year 2025.
Camp4 Therapeutics Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $47.70M | -24.5% |
| 2024 | $63.14M | +151.0% |
| 2023 | -$123.73M | -59.6% |
| 2022 | -$77.53M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $58.67M | +136.9% | +46.7% |
| June 30, 2025 | $39.99M | +127.2% | -22.5% |
| March 31, 2025 | $51.57M | +138.1% | -18.3% |
| December 31, 2024 | $63.14M | +151.0% | +139.7% |
| September 30, 2024 | -$158.97M | -42.5% | -8.1% |
| June 30, 2024 | -$147.11M | -46.3% | -8.7% |
| March 31, 2024 | -$135.33M | -51.6% | -9.4% |
| December 31, 2023 | -$123.73M | -59.6% | -10.9% |
- Camp4 Therapeutics Corp showed a decrease of -24.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Camp4 Therapeutics Corp’s stockholders equity has grown by 161.5% (from -$77.53 million to $47.70 million).
- The most recent figure is from Camp4 Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: